Skip to main content
Industry Update
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 8
- Alex Simpson and
- Sreeram V Ramagopalan
pp915–917
Published Online:15 June 2022
Plain Language Summary of Publication
A plain language summary of the likelihood of symptom relief for patients taking fesoterodine for overactive bladder
- Adrian S Wagg,
- Sender Herschorn,
- Martin Carlsson,
- Mireille Fernet, and
- Matthias Oelke
pp919–925
Published Online:26 July 2022
Short Communication
Economic burden of maternal mortality in the USA, 2018–2020
- Robert S White,
- Briana Lui,
- Joe Bryant-Huppert,
- Rahul Chaturvedi,
- Marguerite Hoyler, and
- Jaime Aaronson
pp927–933
Published Online:14 July 2022
Research Article
Impact of perioperative chemotherapy on survival outcomes among patients with metastatic colorectal cancer to the liver
- Firas Baidoun,
- Zahi Merjaneh,
- Rama Nanah,
- Anas M Saad, and
- Omar Abdel-Rahman
pp935–951
Published Online:5 July 2022
Breast-conserving surgery versus mastectomy for older women with triple-negative breast cancer: population-based study
- Waruiru Mburu,
- Shalini Kulasingam,
- James S Hodges, and
- Beth A Virnig
pp953–967
Published Online:27 July 2022
The cost–effectiveness, of pegcetacoplan compared with ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria, in a UK setting
- Zalmai Hakimi,
- Koo Wilson,
- Eoin McAughey,
- Michal Pochopien,
- Piotr Wojciechowski,
- Mondher Toumi,
- Chris Knight,
- Sujata P Sarda,
- Nikita Patel,
- Catherine Wiseman,
- Nuno Pinto de Castro,
- Jameel Nazir, and
- Richard J Kelly
pp969–985
Published Online:7 July 2022
The acute effects of action observation training on upper extremity functions, cognitive processes and reaction times: a randomized controlled trial
- Yusuf Emuk,
- Turhan Kahraman, and
- Yesim Sengul
pp987–998
Published Online:30 June 2022